Abstract
A series of ternary copper(II)-1,10-phenanthroline complexes with glycine and methylated glycine derivatives, [Cu(phen)(aa)(H2O)]NO3·xH2O 1–4 (amino acid (aa): glycine (gly), 1; dl-alanine (dl-ala), 2; 2,2-dimethylglycine (C-dmg), 3; sarcosine (sar), 4), were synthesized and characterized by FTIR, elemental analysis, electrospray ionization–mass spectra (ESI–MS), UV–visible spectroscopy and molar conductivity measurement. The determined X-ray crystallographic structures of 2 and 3 show each to consist of distorted square pyramidal [Cu(phen)(aa)(H2O)]+ cation, a nitrate counter anion, and with or without lattice water, similar to previously reported structure of [Cu(phen)(gly)(H2O)]NO3·1½H2O. It is found that 1–4 exist as 1:1 electrolytes in aqueous solution, and the cationic copper(II) complexes are at least stable up to 24 h. Positive-ion ESI–MS spectra show existence of only undissociated [Cu(phen)(aa)]+ species. Electron paramagnetic resonance, gel electrophoresis, fluorescence quenching, and restriction enzyme inhibition assay were used to study the binding interaction, binding affinity and selectivity of these complexes for various types of B-form DNA duplexes and G-quadruplex. All complexes can bind selectively to DNA by intercalation and electrostatic forces, and inhibit topoisomerase I. The effect of the methyl substituents of the coordinated amino acid in the above complexes on these biological properties are presented and discussed. The IC50 values (24 h) of 1–4 for nasopharyngeal cancer cell line HK1 are in the range 2.2–5.2 μM while the corresponding values for normal cell line NP69 are greater than 13.0 μM. All complexes, at 5 μM, induced 41–60 % apoptotic cell death in HK1 cells but no significant cell death in NP69 cells.
Similar content being viewed by others
References
Adams J (2004) The proteasome: a suitable antineoplastic target. Nat Rev Cancer 4:349–360
Arimondo PB, Thomas CJ, Oussedik K, Baldeyrou B, Mahieu C, Halby L, Guianvarc’h D, Lansiaux A, Hecht SM, Bailly C, Giovannangeli C (2006) Exploring the cellular activity of camptothecin-triple-helix-forming oligonucleotide conjugates. Mol Cell Biol 26:324–333
Arjmand F, Muddassir M (2010) Design and synthesis of heterobimetallic topoisomerase I and II inhibitor complexes: in vitro DNA binding, interaction with 5′-GMP and 5′-TMP and cleavage studies. J Photochem Photobiol B 101:37–46
Beretta GL, Perego P, Zunino F (2008) Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors. Expert Opin Ther Targets 12:1243–1256
Bolos C, Christidis PC, Will G, Wiehl L (1996) Synthesis and characterisation of Cu(II) complexes with the 2-acetamido-N-(4-methyl-2-thiazolyl) (amtz) ligand. The crystal structure of [Cu(amtz)2H2O](NO3)2. Inorg Chim Acta 248:209–213
Borger DL, Fink BE, Bruette SR, Tse WC, Hedrick MP (2001) A simple, high-resolution method for establishing DNA binding affinity and sequence selectivity. J Am Chem Soc 123:5878–5891
Bruker (2009) APEX2, SAINT and SADABS. Bruker AXS Inc, Madison
Capranico G, Binaschi M, Borgnetto ME, Zunino F, Palumbo M (1997) A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons. Trends Pharmacol Sci 18:323–329
Chashoo G, Singh SK, Sharma PR, Mondhe DM, Hamid A, Saxena A, Andotra SS, Shah BA, Qazi NA, Taneja SC, Saxena AK (2011) A propionyloxy derivative of 11-keto-β-boswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase I & II inhibition. Chem-Biol Interact 189:60–71
Chen CH, Sigman DS (1986) Nuclease activity of 1,10-phenanthroline-copper sequence-specific targeting. Proc Natl Acad Sci USA 83:7147–7151
Chikira M (2008) DNA-fiber EPR spectroscopy as a tool to study DNA–metal complex interactions: DNA binding of hydrated Cu(II) ions and Cu(II) complexes of amino acids and peptides. J Inorg Biochem 102:1016–1024
Chikira M, Inoue M, Nagane R, Harada W, Shindo H (1997) How amino acids control the binding of Cu(II) ions to DNA (II): Effect of basic amino acid residues and the chirality on the orientation of the complexes. J Inorg Biochem 66:131–139
Chikira M, Tomizawa YM, Fukita D, Sugizaki T, Sugawara N, Yamazaki T, Sasano A, Shindo H, Palaniandavar M, Antholine WE (2002) DNA-fiber EPR study of the orientation of Cu(II) complexes of 1,10-phenanthroline and its derivatives bound to DNA: mono(phenanthroline)-copper(II) and its ternary complexes with amino acids. J Inorg Biochem 89:163–173
Chuang N-N, Lin C-L, Chen H-K (1996) Modification of DNA topoisomerase I enzymatic activity with phosphotyrosyl protein phosphatase and alkaline phosphatase from the hepatopancreas of the shrimp Penaeus japonicus (Crustacea: Decapoda). Comp Biochem Physiol 114B:145–151
Daniel KG, Gupta P, Harbach RH, Guida WC, Ping Dou Q (2004) Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells. Biochem Pharm 67:1139–1151
Eriksson M, Leijon M, Hiort C, Norden B, Grasuland A (1994) Binding of Δ- and Λ-[Ru(phen)3]2+ to [d(CGCGATCGCG)]2 studied by NMR. Biochemistry 33:5031–5040
Erkkila KE, Odom DT, Barton JK (1999) Recognition and reaction of metallointercalators with DNA. Chem Rev 99:2777–2796
Francois JC, Saison-Behmoaras T, Chassignol M, Thuong NT, Helene C (1989) Sequence-targeted cleavage of single- and double-stranded DNA by oligothymidylates covalently linked to 1,10-phenanthroline. J Biol Chem 264:5891–5898
Franklin CA, Fry JV, Collins JG (1996) NMR evidence for sequence-specific DNA minor groove binding by bis(ethylenediamine)platinum(II). Inorg Chem 35:7541–7545
Gallori E, Vettori C, Alessio E, Vilchez FG, Vilaplana R, Orioli P, Casini A, Messori L (2000) DNA as a possible target for antitumor ruthenium(III) complexes: a spectroscopic and molecular biology study of the interactions of two representative antineoplastic ruthenium(III) complexes with DNA. Arch Biochem Biophys 376:156–162
Gan J-H, Sheng J, Huang Z (2011) Chemical and structural biology of nucleic acids and protein-nucleic acid complexes for novel drug discovery. Sci China Chem 54:3–23
Gao F, Chao H, Zhou F, Chen X, Wei Y-F, Ji L-N (2008) Synthesis, GC selective DNA binding and topoisomerase II inhibition activities of ruthenium(II) polypyridyl complex containing 11-aminopteridino[6,7-f][1,10]phenanthrolin-13(12H)-one. J Inorg Biochem 102:1050–1059
Gouveris P, Skopelitis E, Tsavaris N (2010) DNA replication—current advances. In: Seligmann H (ed) Topoisomeras I and II expression in recurrent colorectal cancer cells: a dubious matter. ISBN: 978-953-307-593-8, InTech
Halder P, Zangrando E (2010) Copper(II) α-hydroxycarboxylate complexes of bis(2-pyridylcarbonyl)amine: from mononuclear complex to one-dimensional coordination polymer. Polyhedron 29:434–440
Ikotun OF, Higbee EM, Ouellette W, Doyle RP (2009) Pyrophosphate-bridged complexes with picomolar toxicity. J Inorg Biochem 103:1254–1264
Kikuta E, Matsubara R, Katsube N, Koike T, Kimura E (2000) Selective recognition of consecutive G sequence in double-stranded DNA by a zinc(II)–macrocyclic tetraamine complex appended with an anthraquinone. J Inorg Biochem 82:239–249
Kostova I (2006) Platinum complexes as anticancer agents: recent patents on anti-drugs. Cancer Drug Discov 1:1–22
Krotz AH, Kuo LY, Shields TP, Barton JK (1993) DNA recognition by rhodium(III) polyamine intercalators: considerations of hydrogen bonding and van der Waals interactions. J Am Chem Soc 115:3877–3882
Kumar Singh S, Joshi S, Ranjan Singh A, Saxena JK, Pandey DS (2007) DNA binding and topoisomerase II inhibitory activity of water-soluble ruthenium(II) and rhodium(III) complexes. Inorg Chem 46:10869–10876
Meistermann I, Moreno V, Prieto MJ, Moldrheim E, Sletten E, Khalid S, Rodger PM, Peberdy JC, Isaac CJ, Rodger A, Hannon MJ (2002) Intramolecular DNA coiling mediated by metallo-supramolecular cylinders: differential binding of P and M helical enantiomers. Proc Natl Acad Sci USA 99:5069–5074
Mestre B, Pitié M, Loup C, Claparols C, Pratviel G, Meunier B (1997) Influence of the nature of the porphyrin ligand on the nuclease activity of metalloporphyrin-oligonucleotide conjugates designed with cationic, hydrophobic or anionic metalloporphyrins. Nucl Acids Res 25:1022–1027
Miller KM, Rodriguez R (2011) G-quadruplexes: selective DNA targeting for cancer therapeutics. Expert Rev Clin Pharmacol 4:139–142
Monchaud D, Allain C, Bertrand H, Smargiasso N, Rosu F, Gabelica V, De Cian A, Mergny J-L, Teulade-Fichou M-P (2008) Ligands playing musical chairs with G-quadruplex DNA: a rapid and simple displacement assay for identifying selective G-quadruplex binders. Biochimie 90:1207–1223
Nagesh N, Krishnaiah A (2003) A comparative study on the interaction of acridine and synthetic bis-acridine with G-quadruplex structure. J Biochem Biophys Methods 57:65–74
Nakabayashi Y, Iwamoto N, Inada H, Yamauchi O (2006) DNA-binding properties of flexible diamine bridged dinuclear ruthenium(II)-2,2′-bipyridine complexes. Inorg Chem Commun 9:1033–1036
Neidle S (2010) Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS J 277:1118–1125
Patra AK, Bhowmick T, Ramakumar S, Chakravarty AR (2007) Metal-based netropsin mimics showing AT-selective DNA binding and DNA cleavage activity at red light. Inorg Chem 46:9030–9032
Pommier Y (2006) Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 6:789–802
Rajendiran V, Murali M, Suresh E, Palaniandavar M, Periasamy VS, Akbarsha MA (2008) Non-covalent DNA binding and cytotoxicity of certain mixed-ligand ruthenium(II) complexes of 2,2′-dipyridylamine and diimines. Dalton Trans 16:2157–2170
Rajendran A, Nair BU (2006) Unprecedented dual binding behaviour of acridine group of dye: a combined experimental and theoretical investigation for the development of anticancer chemotherapeutic agents. Biochim Biophys Acta 1760:1794–1801
Rao VA, Agama K, Holbeck S, Pommier Y, Batracylin (NSC 320846) (2007) A dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage. Cancer Res 67:9971–9979
Reichmann RE, Rice SA, Thomas CA, Doty P (1954) A further examination of the molecular weight of desoxypentose nucleic acid. J Am Chem Soc 76:3047–3053
Rothenberg ML (1997) Topoisomerase I inhibitors: review and update. Ann Oncol 8:837–855
Ruíz P, Ortiz R, Perelló L, Alzuet G, González-Álvarez M, Liu-González M, Sanz-Ruíz F (2007) Synthesis, structure and nuclease properties of several binary and ternary complexes of copper(II) with norfloxacin and 1,10-phenanthroline. J Biol Inorg Chem 101:831–840
Rupesh KR, Deepalatha S, Krishnaveni M, Venkatesan R, Jayachandran S (2006) Synthesis, characterization and in vitro biological activity studies of Cu–M (M = Cu2+, Co2+, Ni2+, Mn2+, Zn2+) bimetallic complexes. Eur J Med Chem 41:1494–1503
Seng HL (2010) Duplex and G-quadruplex DNA binding, nucleolytic property and topoisomerase I inhibition by different series of metal(II) complexes. Dissertation, Universiti Tunku Abdul Rahman, Kampar
Seng HL, Von ST, Tan KW, Maah MJ, Ng SW, Raja Abd Rahman RNZ, Caracelli I, Ng CH (2009) Crystal structure, DNA binding studies, nucleolytic property and topoisomerase I inhibition of zinc complex with 1,10-phenanthroline and 3-methyl-picolinic acid. Biometals 23:99–118
Sheldrick GM (1996) SADABS. University of Göttingen, Germany
Sheldrick GM (1997a) SHELXS 97 program for crystal structure solution. University of Göttingen, Göttingen
Sheldrick GM (1997b) SHELXL-97 program for crystal structure refinement. University of Göttingen, Göttingen
Sheldrick GM (2008) A short history of SHELX. Acta Cryst A 64:112
Sitlani A, Barton JK (1994) Sequence-specific recognition of DNA by phenanthrenequinone diimine complexes of rhodium(III): importance of steric and van der Waals interactions. Biochemistry 33:12100–12108
Sitlani A, Dupureur CM, Barton JK (1993) Enantiospecific palindromic recognition of 5′-d(CTCTAGAG)-3′ by a novel rhodium intercalator:analogies to a DNA-binding protein. J Am Chem Soc 115:12589–12590
Snow AM, Sheardy RD (2001) Locating cobalt-binding sites on DNA using restriction endonucleases. Methods Enzymol 340:519–528
Souza V, Dong YB, Zhou HS, Zacharias W, McMasters KM (2005) SW-620 cells treated with topoisomerase I inhibitor SN-38: gene expression profiling. J Transl Med 44:1–7
Sunami S, Nishimura T, Nishimura I, Ito S, Arakawa H, Ohkubo M (2009) Synthesis and biological activities of topoisomerase I inhibitors, 6-arylmethylamino analogues of edotecarin. J Med Chem 52:3225–3237
Sung FL, Poon TCW, Hui EP, Ma BBY, Liong E, To KF, Huang DPWS, Chan ATC (2005) Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells. In Vivo 19:237–246
Tan KW, Ng CH, Mohd Jamil M, Ng SW (2008) Chlorido(2-methyl-4-oxo-4H-pyran-3-olato-κ2 O 3,O 4)(1,10-phenanthroline-κ2 N,N′)copper(II). Acta Cryst E64:m1104
Tan J, Jun L, Wang B (2010) From GC-rich DNA binding to the repression of survivin gene for quercetin nickel(II) complex: implications for cancer therapy. Biometals 23:1075–1084
Teicher BA (2008) Next generation topoisomerase I inhibitors: rationale and biomarker strategies. Biochem Pharmacol 75:1262–1271
To YF, Raymond Sun W-Y, Chen Y, Vera Chan S-F, Yu W-Y, Paul Tam K-H, Che C-M, Steve Lin C-L (2009) Gold(III) porphyrin complex is more potent than cisplatin in inhibiting growth of nasopharyngeal carcinoma in vitro and in vivo. Int J Cancer 124:1971–1979
Vermorken JB, Trigo J, Hitt R, Koralewski P, Diaz-Rubio E, Rolland F, Knecht R, Amellal N, Schueler A, Baselga J (2007) Open label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 25:2171–2177
Wang X, Wang L-K, Kinsbury WD, Johnson RK, Hecht SM (1998) Differential effects of camptothecin derivatives on topoisomerase I-mediated DNA structure modification. Biochemistry 37:9399–9408
Wang Y, He Q-Y, Che C-M, Chiu J-F (2006) Proteomic characterization of cytotoxic mechanism of gold(III) porphyrin 1a, a potential anticancer drug. Proteomics 6:131–142
Webb MR, Ebeler SE (2008) Anthocyanin interactions with DNA: intercalation topoisomerase I inhibition and oxidative reactions. J Food Biochem 32:576–596
Wheate NJ, Collins JG (2000) A 1H NMR study of the oligonucleotide binding of [(en)Pt(μ-dpzm)2Pt(en)]Cl4. J Inorg Biochem 78:313–320
Wu XJ, Hua X (2007) Selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound. Cancer Biol Ther 6:646–647
Wu Y, Chen H, Yang P, Xiong Z (2005) Racemic d,l-[Co(phen)2dpq]3+–DNA interactions: investigation into the basis for minor-groove binding and recognition. J Inorg Biochem 99:1126–1134
Xu L, Liao G-L, Chen X, Zhao C-Y, Chao H, Ji L-N (2010) Trinuclear Ru(II) polypyridyl complexes as human telomeric quadruplex DNA stabilizers. Inorg Chem Commun 13:1050–1053
Zeglis BM, Pierre VC, Barton JK (2007) Metallo-intercalators and metallo-insertors. Chem Commun 44:4565–4579
Zhai S, Yang L, Cindy Cui Q, Sun Y, Ping Dou Q, Yan B (2010) Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells. J Biol Inorg Chem 15:259–269
Zhang S, Zhou J (2008) Ternary copper(II) complex of 1,10-phenanthroline and l-glycine: crystal structure and interaction with DNA. J Coord Chem 61:2488–2498
Acknowledgments
This work is supported by MOSTI eScience grant (02-02-SF0033). We also thank the Director General of Health Malaysia for his permission to publish this article and the Director of the Institute for Medical Research for her support. Makoto Chikira acknowledges financial support from Grant-in-Aid for Science Research (No. 21550070) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. Statistical analysis on apoptosis data was done by Lee How Chinh.
Author information
Authors and Affiliations
Corresponding author
Additional information
Malaysian Patent No PI 2012700421.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Seng, HL., Wang, WS., Kong, SM. et al. Biological and cytoselective anticancer properties of copper(II)-polypyridyl complexes modulated by auxiliary methylated glycine ligand. Biometals 25, 1061–1081 (2012). https://doi.org/10.1007/s10534-012-9572-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-012-9572-4